Benign prostatic hyperplasia (BPH)

Displaying 5 studies

  • Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II Scottsdale/Phoenix, AZ

    Single-arm, interventional pivotal clinical trial collecting patient data from use of the AQUABEAM System, a personalized image-guided waterjet resection system that utilizes a high-velocity saline stream to resect and remove prostate tissue in males suffering from Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH).The primary endpoints for safety and effectiveness will be measured at 3 months post-treatment. All treated subjects will be followed out to 12 months to collect long-term clinical data.

  • Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH Rochester, MN

    The purpose of this study is to evaluate the safety and efficacy of a single treatment of PRX302 for the treatment of Benign Prostatic Hyperplasia (BPH) as compared to placebo.

  • Ultrasound Bladder Vibrometry Rochester, MN

    The purpose of this study is tp evaluate the effectiveness of quantitative ultrasound bladder vibrometry (QUBV) as a noninvasive tool for detrusor overactivity assessment and for BPH treatment selection.

  • A Study to Assess if Bladder Stiffness (Compliance) can be Evaluated using Ultrasound Rochester, MN

    The purpose of this research study to help us understand whether a type of ultrasound can measure bladder stiffness (or compliance).

  • Flexiva Pulse Registry Scottsdale/Phoenix, AZ

    The purpose of this study is to obtain post-market safety and effectiveness data for FlexivaTM Pulse High Power Single-Use Laser Fibers during lithotripsy and soft tissue procedure of holmium laser enucleation of the prostate (HoLEP).

.

Mayo Clinic Footer